Loomis Sayles & CO L P Viatris Inc Transaction History

Loomis Sayles & CO L P

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$8.77 - $10.85 $289 - $358	33 Added 1.63%	2,054 $22,000
Q3 2023 Nov 09, 2023	BUY	$9.59 - $11.35 $2,761 - $3,268	288 Added 16.62%	2,021 $20,000
Q2 2023 Aug 11, 2023	BUY	$9.02 - $10.29 $6,521 - $7,439	723 Added 71.58%	1,733 $17,000
Q1 2023 May 11, 2023	SELL	$9.2 - $12.26 $22,346 - $29,779	-2,429 Reduced 70.63%	1,010 $10,000
Q4 2022 Feb 10, 2023	BUY	$8.72 - $11.56 $27,616 - $36,610	3,167 Added 1164.34%	3,439 $38,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $110,223 - $144,667	-12,998 Reduced 97.95%	272 $2,000
Q2 2022 Aug 05, 2022	BUY	$9.95 - $12.27 $132,036 - $162,822	13,270 New	13,270 $139,000
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $6.01 Million - $8.2 Million	-442,535 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $6.33 Million - $8.29 Million	442,535 New	442,535 $8.29 Million

1,103

931M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.